Cargando…

Dose uniformity of budesonide Easyhaler® under simulated real-life conditions and with low inspiration flow rates

Budesonide Easyhaler® multidose dry powder inhaler is approved for the treatment of asthma. Objectives were to determine the delivered dose (DD) uniformity of budesonide Easyhaler® in simulated real-world conditions and with different inspiration flow rates (IFRs). Three dose delivery studies were p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haikarainen, Jussi, Rytilä, Paula, Roos, Sirkku, Metsärinne, Sirpa, Happonen, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100165/ https://www.ncbi.nlm.nih.gov/pubmed/29216744 http://dx.doi.org/10.1177/1479972317745733

Ejemplares similares

Consistent Dosing Through the Salmeterol–Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime
por: Turpeinen, Anni, et al.
Publicado: (2021)

Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler
por: Lähelmä, Satu, et al.
Publicado: (2015)

In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial
por: Jõgi, Rain, et al.
Publicado: (2019)

A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Switching to the Dry-Powder Inhaler Easyhaler(®): A Narrative Review of the Evidence
por: Lavorini, Federico, et al.
Publicado: (2021)

Preference for Easyhaler(®) Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study
por: Alvarez-Gutiérrez, Francisco Javier, et al.
Publicado: (2021)

Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler(®) for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported Outcomes
por: Tamási, Lilla, et al.
Publicado: (2018)

Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler(®) Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
por: Gálffy, Gabriella, et al.
Publicado: (2019)

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters
por: Malmberg, L Pekka, et al.
Publicado: (2010)

Today’s improvement in asthma treatment: role of MART and Easyhaler
por: Di Marco, Fabiano
Publicado: (2020)

Inhaler Competence and Patient Satisfaction with Easyhaler(®): Results of Two Real-Life Multicentre Studies in Asthma and COPD
por: Gálffy, Gabriella, et al.
Publicado: (2013)

Continuous flow process for preparing budesonide
por: Phull, Manjinder Singh, et al.
Publicado: (2022)

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
por: Price, David, et al.
Publicado: (2014)

Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler(®) Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings
por: Tamási, Lilla, et al.
Publicado: (2022)

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data
por: Müller, Veronika, et al.
Publicado: (2016)

Easyhaler(®): an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
por: Lavorini, Federico
Publicado: (2019)

Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
por: Kirjavainen, Merja, et al.
Publicado: (2018)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Fraction of Inspired Oxygen With Low-Flow Versus High-Flow Devices: A Simulation Study
por: Kojima, Yuki, et al.
Publicado: (2022)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017)

Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler(®) dry powder inhaler: a pooled analysis of two randomized controlled trials
por: Malmberg, L. Pekka, et al.
Publicado: (2021)

A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler(®) in routine clinical practice
por: Vinge, Ines, et al.
Publicado: (2021)

Budesonide and fluticasone and adrenal suppression
por: Fouda, Mona A, et al.
Publicado: (2012)

Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017)

Craniofacial and oral alterations in patients with Neurofibromatosis 1
por: Visnapuu, Vivian, et al.
Publicado: (2018)

Flow uniformity data on 3D printed flow distributors
por: Mendonça Lopes, Mariana Garcia, et al.
Publicado: (2019)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers
por: Rönmark, Per, et al.
Publicado: (2018)

High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Use of Budesonide in the Treatment of Microscopic Colitis
por: Tangri, Vikram, et al.
Publicado: (2010)

Optimal control of diffuser shapes for non-uniform flow
por: Benham, G. P., et al.
Publicado: (2018)

Controlling fluid flow to improve cell seeding uniformity
por: Reynolds, Paul M., et al.
Publicado: (2018)

S-duct flow distortion with non-uniform inlet conditions
por: Migliorini, Matteo, et al.
Publicado: (2022)

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
por: Hanania, Nicola A., et al.
Publicado: (2020)

Non-uniform Segmental Range of Motion of the Thoracic Spine During Maximal Inspiration and Exhalation in Healthy Subjects
por: Burgos, Jesús, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_so0ppftmb5iqtlt91gtn3f89rd